Discovery and Characterization of Natural Product Systems
天然产物系统的发现和表征
基本信息
- 批准号:10618882
- 负责人:
- 金额:$ 38.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-06-01 至 2026-05-31
- 项目状态:未结题
- 来源:
- 关键词:AchievementAllyAntibiotic ResistanceAntibioticsAreaBacteriaCatalytic DomainComplexDevelopmentDiels Alder reactionEnzymesGatekeepingHydroxylationIndole AlkaloidsMacrolidesMethodsMolecular MachinesNatural ProductsPathway interactionsPharmacologic SubstanceProcessProductivityPublicationsReactionReportingResearchStructureSystemTestingTherapeutic AgentsType I Polyketide SynthaseWorkcopingflexibilityglycosylationhuman pathogenmicrobialnext generationnovel strategiespolyketide synthasepolyketidesprograms
项目摘要
Project Summary. In this competing renewal of R35 GM118101, we propose to focus on investigating and
developing biocatalytic systems that generate complex natural products with high potential as therapeutic
agents. This program has been highly productive with 34 publications over the past four years. Major progress
continues toward studies on the function and structure of modular polyketide synthases (PKSs) from bacteria. A
second thematic area involves studies on diverse bacterial and fungal indole alkaloid pathways for which we
have reported important achievements on characterizing biosynthetic enzymes that catalyze pericyclic (e. g.
Cope, Diels-Alder) reactions. We plan to build on these studies and also expand work on allied tailoring reactions
for indole alkaloid structural diversification.
Our work in the type I PKS area will focus on function and structure of key catalytic domains that we have
identified to be gatekeepers in the catalytic cycle. By employing natural and unnatural advanced polyketide chain
elongation intermediates with late stage PKS modules, we plan to develop methods to expand the biocatalytic
potential of these remarkable molecular machines for assembly of macrolactone structures. Further glycosylation
and late-stage hydroxylation/epoxidation methods will be employed to generate next generation macrolides for
testing against a range of antibiotic-resistant human pathogens.
Our work in the microbial indole alkaloids will focus on natural products whose core ring systems are derived
from biocatalytic pericyclic reactions. Mechanistic understanding of these unusual processes is rapidly emerging,
and their apparent flexibility indicates high potential for metabolite structural diversification. These efforts will be
augmented by exploring late-stage tailoring enzymes capable of further modifying core indole alkaloid structures
to generate a range of biologically active products with significant pharmaceutical potential.
项目摘要。在R35 GM 118101的竞争性更新中,我们建议重点调查和
开发生物催化系统,产生具有高治疗潜力的复杂天然产物
剂.在过去的四年里,该方案取得了很高的成果,出版了34篇出版物。重大进展
继续研究细菌模块化聚酮合酶(PKS)的功能和结构。一
第二个主题领域涉及对不同细菌和真菌吲哚生物碱途径的研究,
已经报道了在表征催化周环(e. G.
科普,狄尔斯-阿尔德)反应。我们计划在这些研究的基础上,扩大有关剪裁反应的工作
吲哚生物碱结构多样化。
我们在I型PKS领域的工作将集中在我们所拥有的关键催化结构域的功能和结构上
被认为是催化循环中的看门人。通过使用天然和非天然的高级聚酮链
延伸中间体与后期阶段PKS模块,我们计划开发方法,以扩大生物催化
这些卓越的分子机器组装大环内酯结构的潜力。进一步糖基化
和后期羟基化/环氧化方法将用于产生下一代大环内酯,
对一系列具有抗药性的人类病原体进行测试。
我们在微生物吲哚生物碱方面的工作将集中在核环系统衍生的天然产物上
来自于生物催化的周环反应。对这些不寻常过程的机械理解正在迅速出现,
并且它们明显的灵活性表明代谢物结构多样化的高潜力。这些努力将
通过探索能够进一步修饰核心吲哚生物碱结构的后期剪裁酶来增强
以产生一系列具有显著制药潜力的生物活性产品。
项目成果
期刊论文数量(23)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Engineering P450 TamI as an Iterative Biocatalyst for Selective Late-Stage C-H Functionalization and Epoxidation of Tirandamycin Antibiotics.
- DOI:10.1021/acscatal.1c01460
- 发表时间:2021-07-02
- 期刊:
- 影响因子:12.9
- 作者:Espinoza RV;Haatveit KC;Grossman SW;Tan JY;McGlade CA;Khatri Y;Newmister SA;Schmidt JJ;Garcia-Borràs M;Montgomery J;Houk KN;Sherman DH
- 通讯作者:Sherman DH
Chemoenzymatic synthesis of fluorinated polyketides.
- DOI:10.1038/s41557-022-00996-z
- 发表时间:2022-09
- 期刊:
- 影响因子:21.8
- 作者:
- 通讯作者:
Thioesterase domain swapping of a linear polyketide tautomycetin with a macrocyclic polyketide pikromycin in Streptomyces sp. CK4412.
- DOI:10.1007/s10295-016-1790-2
- 发表时间:2016-08
- 期刊:
- 影响因子:3.4
- 作者:Tripathi A;Choi SS;Sherman DH;Kim ES
- 通讯作者:Kim ES
Identification of an unexpected shunt pathway product provides new insights into tirandamycin biosynthesis.
意外分流途径产物的鉴定为替兰霉素生物合成提供了新的见解
- DOI:10.1016/j.tetlet.2016.11.080
- 发表时间:2016-12-28
- 期刊:
- 影响因子:1.8
- 作者:Zhang X;Li Z;Du L;Chlipala GE;Lopez PC;Zhang W;Sherman DH;Li S
- 通讯作者:Li S
Ribosome-binding and anti-microbial studies of the mycinamicins, 16-membered macrolide antibiotics from Micromonospora griseorubida.
- DOI:10.1093/nar/gkab684
- 发表时间:2021-09-20
- 期刊:
- 影响因子:14.9
- 作者:Breiner-Goldstein E;Eyal Z;Matzov D;Halfon Y;Cimicata G;Baum M;Rokney A;Ezernitchi AV;Lowell AN;Schmidt JJ;Rozenberg H;Zimmerman E;Bashan A;Valinsky L;Anzai Y;Sherman DH;Yonath A
- 通讯作者:Yonath A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID H SHERMAN其他文献
DAVID H SHERMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID H SHERMAN', 18)}}的其他基金
Discovery and Characterization of Natural Product Systems
天然产物系统的发现和表征
- 批准号:
10418743 - 财政年份:2016
- 资助金额:
$ 38.11万 - 项目类别:
Discovery and Characterization of Natural Product Systems-Research Supplement to Promote Diversity
天然产物系统的发现和表征-促进多样性的研究补充
- 批准号:
9905666 - 财政年份:2016
- 资助金额:
$ 38.11万 - 项目类别:
Discovery and Characterization of Natural Product Systems
天然产物系统的发现和表征
- 批准号:
10206351 - 财政年份:2016
- 资助金额:
$ 38.11万 - 项目类别:
Discovery and Characterization of Natural Product Systems
天然产物系统的发现和表征
- 批准号:
9277486 - 财政年份:2016
- 资助金额:
$ 38.11万 - 项目类别:
Discovery of Natural Product based Drugs and Bioenergetic Materials from CR
从 CR 中发现基于天然产物的药物和生物能材料
- 批准号:
8488515 - 财政年份:2009
- 资助金额:
$ 38.11万 - 项目类别:
of Natural Product based Drugs and Bioenergetic Materials from Costa Rican Biota
来自哥斯达黎加生物群的基于天然产物的药物和生物能材料
- 批准号:
7741888 - 财政年份:2009
- 资助金额:
$ 38.11万 - 项目类别:
Discovery of Natural Product based Drugs and Bioenergetic Materials from CR
从 CR 中发现基于天然产物的药物和生物能材料
- 批准号:
8287155 - 财政年份:2009
- 资助金额:
$ 38.11万 - 项目类别:
Discovery of Natural Product based Drugs and Bioenergetic Materials from CR
从 CR 中发现基于天然产物的药物和生物能材料
- 批准号:
8112694 - 财政年份:2009
- 资助金额:
$ 38.11万 - 项目类别:
Discovery of Natural Product based Drugs and Bioenergetic Materials from CR
从 CR 中发现基于天然产物的药物和生物能材料
- 批准号:
7935324 - 财政年份:2009
- 资助金额:
$ 38.11万 - 项目类别:
相似海外基金
台湾の小中学校におけるジェンダー平等教育の実践-教員が「ally」となるためにはー
台湾中小学性别平等教育实践——让教师成为“盟友”
- 批准号:
24K05716 - 财政年份:2024
- 资助金额:
$ 38.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Allostatic Load in Latino Youth (ALLY) study: The Role of Discrimination and Environmental Racism
拉丁裔青年的均衡负荷 (ALLY) 研究:歧视和环境种族主义的作用
- 批准号:
10677710 - 财政年份:2022
- 资助金额:
$ 38.11万 - 项目类别:
Turning an enemy into an ally: Privacy In Machine Learning (Pri-ML)
化敌为友:机器学习中的隐私 (Pri-ML)
- 批准号:
DGECR-2022-00376 - 财政年份:2022
- 资助金额:
$ 38.11万 - 项目类别:
Discovery Launch Supplement
Turning an enemy into an ally: Privacy In Machine Learning (Pri-ML)
化敌为友:机器学习中的隐私 (Pri-ML)
- 批准号:
RGPIN-2022-03721 - 财政年份:2022
- 资助金额:
$ 38.11万 - 项目类别:
Discovery Grants Program - Individual
Animals, Lifeways and Lifeworlds in Yup'ik Archaeology (ALLY): Subsistence, Technologies, and Communities of Change
尤皮克考古学中的动物、生活方式和生命世界(ALLY):生存、技术和变革社区
- 批准号:
AH/N504543/1 - 财政年份:2016
- 资助金额:
$ 38.11万 - 项目类别:
Research Grant
Marie Duval presents Ally Sloper: the female cartoonist and popular theatre in London 1869-85.
玛丽·杜瓦尔 (Marie Duval) 介绍艾丽·斯洛珀 (Ally Sloper):1869-85 年伦敦的女漫画家和受欢迎的剧院。
- 批准号:
AH/M000257/1 - 财政年份:2014
- 资助金额:
$ 38.11万 - 项目类别:
Research Grant
Development of new function by suppression of martensitic transition in Fe-Pt ally
通过抑制 Fe-Pt 合金中的马氏体转变开发新功能
- 批准号:
21860009 - 财政年份:2009
- 资助金额:
$ 38.11万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Studies on the biocompatibility of magnesium ally implant materials
镁合金植入材料的生物相容性研究
- 批准号:
366590-2008 - 财政年份:2008
- 资助金额:
$ 38.11万 - 项目类别:
University Undergraduate Student Research Awards
High strength and high conductivity nanoparticle-precipitated copper ally : optimizaiton of thermomechanical processing
高强度和高导电性纳米颗粒沉淀铜合金:热机械加工的优化
- 批准号:
15560601 - 财政年份:2003
- 资助金额:
$ 38.11万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Fabrication of Integrated Air Valve Chip Using Shape Memory Ally Thin Film
使用形状记忆合金薄膜制造集成气阀芯片
- 批准号:
06555072 - 财政年份:1994
- 资助金额:
$ 38.11万 - 项目类别:
Grant-in-Aid for Scientific Research (A)














{{item.name}}会员




